Publication | Closed Access

Development and Validation of a Screening Assay for the Evaluation of Putative Neuroprotective Agents in the Treatment of Parkinson’s Disease

Neurodegenerative DiseasesMedicineParkinson ’Screening AssayNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeurologyNeuroscienceDopaminePutative Neuroprotective AgentsPharmacologyNeurochemistryMovement Disorders